Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022

BUY
$42.51 - $54.02 $101,471 - $128,945
2,387 New
2,387 $105,000
Q1 2022

Apr 05, 2022

SELL
$48.09 - $57.79 $335,812 - $403,547
-6,983 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$47.19 - $62.68 $5,662 - $7,521
-120 Reduced 1.69%
6,983 $366,000
Q3 2021

Oct 15, 2021

SELL
$56.91 - $67.81 $13,829 - $16,477
-243 Reduced 3.31%
7,103 $425,000
Q2 2021

Jul 21, 2021

BUY
$64.02 - $71.72 $119,525 - $133,901
1,867 Added 34.08%
7,346 $498,000
Q1 2021

Apr 05, 2021

SELL
$53.26 - $68.08 $12,995 - $16,611
-244 Reduced 4.26%
5,479 $359,000
Q4 2020

Jan 20, 2021

SELL
$43.41 - $56.51 $289,023 - $376,243
-6,658 Reduced 53.78%
5,723 $322,000
Q3 2020

Oct 19, 2020

BUY
$47.43 - $60.75 $587,230 - $752,145
12,381 New
12,381 $601,000
Q1 2020

Apr 23, 2020

SELL
$32.82 - $81.13 $582,587 - $1.44 Million
-17,751 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$60.96 - $77.7 $81,259 - $103,574
-1,333 Reduced 6.98%
17,751 $1.37 Million
Q3 2019

Oct 10, 2019

SELL
$55.78 - $68.08 $81,606 - $99,601
-1,463 Reduced 7.12%
19,084 $1.21 Million
Q2 2019

Aug 12, 2019

BUY
$53.69 - $65.47 $1.1 Million - $1.35 Million
20,547 New
20,547 $1.2 Million
Q4 2018

Feb 13, 2019

SELL
$47.64 - $71.26 $868,858 - $1.3 Million
-18,238 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$52.03 - $71.41 $105,152 - $144,319
2,021 Added 12.46%
18,238 $1.3 Million
Q2 2018

Aug 14, 2018

BUY
$48.15 - $56.68 $118,737 - $139,772
2,466 Added 17.93%
16,217 $845,000
Q1 2018

May 14, 2018

BUY
$46.03 - $61.28 $67,618 - $90,020
1,469 Added 11.96%
13,751 $718,000
Q4 2017

Feb 14, 2018

BUY
$50.58 - $60.79 $269,641 - $324,071
5,331 Added 76.69%
12,282 $718,000
Q3 2017

Nov 08, 2017

BUY
$53.54 - $68.0 $372,156 - $472,668
6,951
6,951 $386,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.